Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.
about
Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesAssociation between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancerThe effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysisHow do we improve patient compliance and adherence to long-term statin therapy?A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and developmentAssociation between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic reviewCosts and benefits of free medications after myocardial infarction.Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.Impact of prescription benefit coverage limits on sevelamer hydrochloride adherence for patients with ESRD.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represQuality of life declines after first ischemic stroke. The Northern Manhattan StudyFrom the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.Pricing of new vaccines.Medication adherence among community-dwelling patients with heart failureAssociation of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review.An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures.Impact of the introduction of generic latanoprost on glaucoma medication adherence.Does medication adherence following a copayment increase differ by disease burden?The roles of past behavior and health beliefs in predicting medication adherence to a statin regimenAdjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.Potential bias in medication adherence studies of prevalent users.National pharmacare: Time to move forward.[Assurance-médicaments nationale: Le moment d'aller de l'avant].Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based studyMedication Nonadherence After Lung Transplantation in Adult Recipients.Medicines Compliance and Reimbursement Level in Portugal.Non-adherence to statin therapy: a major challenge for preventive cardiology.Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia.Novel incentive-based approaches to adherence.Impediments to adherence to post myocardial infarction medications.Patient co-payment and adherence to statins: a review and case studies.Intentional non-adherence to medications by older adults.Societal value of generic medicines beyond cost-saving through reduced prices.Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients.Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.The effect of increased travel reimbursement rates on health care utilization in the VA.Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.Non-adherence to cardiovascular medications.Effect of electronic prescription on attainment of cholesterol goals.
P2860
Q24188009-72822EA3-9D44-4C93-AEE1-1B799082FADBQ24632347-82B86494-C866-48B5-828D-F539FBE7D1ACQ26829072-87186336-0B42-48D0-B385-F3ECC6E4C903Q27691392-8AB13FF4-9E62-4029-9784-62DF4F00BD69Q28540727-E4EF64FC-AC1B-416F-9393-3B453D94437DQ28541457-8931BE91-B5CB-49A5-869C-05C903D5FFFAQ33585275-1CF4BDCA-7C7F-4330-8975-197EAD486AAAQ33873068-917EC598-5720-4145-8AC6-3F63273025F0Q33931931-9D84C591-54A9-42F9-BC44-CC285266A806Q34046881-4B6AED88-4D53-4E48-817B-3871BFDD3CD2Q34054964-7503CF52-A55C-4714-952A-55064030A771Q34613417-3074CCDB-2647-4A08-B986-E246F28D2CF7Q34663970-E07B17E8-004E-41B9-8450-D18E6DED52DAQ34748351-B9187F9B-A3FA-4226-B5C6-36B9F9E22D4FQ34772182-C1FA4C74-61BA-4976-8226-BFDC172FE07AQ34953788-B845A491-D41A-4323-8DCE-D9136BDCB0EEQ35716882-2D486486-B9AB-423D-8EE0-B114E5E8E561Q35899865-2E44E7B8-181B-4044-B422-E9CD2D0FF236Q36085521-F1D77047-74F4-471E-8D47-05C582EBD8F1Q36289295-B2779EA7-A81C-443C-94C5-5536B945BF4DQ36788354-DA2F0FA5-6C65-4A5F-9417-E93E69747B1BQ37050974-ADA892BE-2563-4588-9B2B-E709DE6EB55CQ37112999-6B8D6B65-FF78-4426-9359-BBFE7AAF0E8AQ37113030-C9180E4B-CBCD-4730-B0A8-0DED26C26EE7Q37293254-478C1694-F980-4D48-9233-CFE646A173E5Q37530975-ABF868CF-7B5F-4F4E-B171-F5A06D67233CQ37606776-7B55AC8A-13D1-4346-AE38-0B79995360FEQ37642755-9FE92D6C-A5B2-4079-AB31-ACA8ABBD2ED4Q37730479-7B3FA5AF-56E8-4D67-83FA-6B6FC4AEF6DCQ38030904-ECDA774D-59CD-4FE5-8C70-628406A4CFC2Q38068349-AF8C17E6-383B-43F2-A97E-3B9AD4DD60EEQ38154826-42B94AC0-8035-4937-A3B9-C893FC137E4FQ38190869-C0A14D80-3ABF-45EA-87CB-E11CC213B2ABQ38361389-FEA01608-AFB0-445D-A13F-B76AECA6CB12Q38954355-985995D2-39FF-4451-A25F-037103700DF8Q40095978-61A434B7-7E4D-4160-95EA-DEE51F388B73Q43580735-96BE3D4B-8C7D-40CB-AE87-20029EFA6F5DQ44871003-61FC297B-92ED-4686-8AB9-65F61F881868Q45230929-FCDB21B0-7BF1-4179-A042-FC9E22CCA26AQ45243866-77638C61-C202-404D-B5C6-5890295189EC
P2860
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of a prescription copay ...... ication adherence in veterans.
@en
Impact of a prescription copay ...... ication adherence in veterans.
@nl
type
label
Impact of a prescription copay ...... ication adherence in veterans.
@en
Impact of a prescription copay ...... ication adherence in veterans.
@nl
prefLabel
Impact of a prescription copay ...... ication adherence in veterans.
@en
Impact of a prescription copay ...... ication adherence in veterans.
@nl
P2093
P2860
P1433
P1476
Impact of a prescription copay ...... dication adherence in veterans
@en
P2093
Bruce Y Lee
Jalpa A Doshi
Jingsan Zhu
Stephen E Kimmel
P2860
P304
P356
10.1161/CIRCULATIONAHA.108.783944
P407
P577
2009-01-12T00:00:00Z